Delivery Order SPE2DE24D0013-SPE2D625F2TXX
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $3,850 firm fixed-price delivery order to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract, numbered 4569219084 and designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a discrete procurement under one of Cepheid's existing federal contract vehicles, continuing the...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $23,100 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California. The contract, designated XPRSARS-COV2-10, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents procurement of diagnostic equipment and/or reagents related to COVID-19...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The Defense Department's Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on September 10, 2025, with an ultimate completion date of September 17, 2025. The contract, which carries no set-aside designation, is classified as a delivery order under contract number XPRSARS-COV2-10. Work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions specializing in advanced diagnostic...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- The Department of Defense's Medical Supply Chain awarded a $1,699.50 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order, designated XPRSARS-COV2-DOD, carries no set-aside designation and represents a continuation of Cepheid's established role as a federal supplier of diagnostic equipment and testing solutions. The contract...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,925 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPRSARS-COV2-10, was executed on July 22, 2025, with a completion date of July 29, 2025, and carries no set-aside designation. This delivery order represents a continuation of the federal government's ongoing procurement of Cepheid's diagnostic testing capabilities, likely...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $2,310 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, carries no set-aside designation and represents a standard procurement under the company's existing contract vehicles. The award references XPRSARS-COV2-10, indicating it is likely associated with...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2TXXDelivery Order
The Defense Department's Medical Supply Chain division awarded a $9,240 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (4569359243 ! XPRSARS-COV2-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with particular expertise in COVID-19 detection and related respiratory pathogen identification. This award likely represents a delivery order against one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Department of Veterans Affairs or Defense Logistics Agency, reflecting the company's established position as a key supplier of molecular diagnostic equipment and reagents to federal healthcare systems. The contract designation referencing XPRSARS-COV-2 indicates the delivery is related to COVID-19 diagnostic capabilities. Cepheid maintains significant federal IDIQ vehicles, including a $32.8 million contract with VA's Veterans Integrated Service Network 6 extending through September 2030, which enables continuous procurement of molecular diagnostic testing system reagents and assays, positioning the company as a critical provider of diagnostic solutions across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 9/8/25 |